Pharmaniaga Berhad operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaniaga Berhad with three other
drug stores in Asia:
Jiangsu Nhwa Pharmaceutical Company Limited
sales of 2.77 billion Chinese Renmimbi [US$414.14 million]
of which 51%
was Medical Industrial Manufacturing),
Chuangmei Pharmaceutical Co Ltd
of Hong Kong
(4.19 billion Hong Kong Dollars [US$539.95 million]
Zhejiang Zhenyuan Co., Ltd.
based in China
(2.16 billion Chinese Renmimbi [US$323.83 million]
of which 78%
was Medicine Wholesales).
During the year ended December of 2015, sales at
Pharmaniaga Berhad were 2.19 billion Malaysian Ringgits (US$543.65 million).
increase of 3.1%
versus 2014, when the company's sales were 2.12 billion Malaysian Ringgits.
This was the fifth consecutive year of sales increases at Pharmaniaga Berhad
(and since 2010, sales have increased a total of 59%).
Sales of Manufacturing saw an increase
that was more than double the company's growth rate: sales were up
12.1% in 2015, from
19.10 million Malaysian Ringgits to 21.41 million Malaysian Ringgits.